GAMMA Investing’s Genenta Science SAEN Stock Holding History

GAMMA Investing’s Portfolio SAEN Stock Details SAEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.77K	Sell	5,389 -4,474	-45%	-$5.35K	﹤0.01%	3762
2026 Q2	$18.1K	Sell	9,863 -4,425	-31%	-$4.78K	﹤0.01%	2888
2026 Q1	$9.6K	Buy	14,288 +11,461	+405%	+$11.6K	﹤0.01%	3087
2025 Q4	$4.21K	Buy	+2,827	New	+$6.66K	﹤0.01%	3355

Other funds holding SAEN

Eurizon Capital SGR SpA Milan $37.6B AUM 38.21% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $3.43B AUM 16.22% 1-Year Est. Return

Financial Planning Navigators Maple Grove, Minnesota $274M AUM 13.83% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's SAEN Position: Q3 2026 in Review

GAMMA Investing reduced its Genenta Science (SAEN) stake by 45% in Q3 2026, selling an estimated $5.35K and leaving 5,389 shares worth $3.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3762.

GAMMA Investing first reported a position in SAEN in Q4 2025 and has held it in 4 quarters since. The position peaked at $18.1K in Q2 2026. 5 funds tracked by Wall St. Rank hold SAEN as of Q3 2026.

GAMMA Investing held 5,389 shares of Genenta Science worth $3.77K as of Q3 2026.
GAMMA Investing sold 4,474 Genenta Science shares in Q3 2026, an estimated $5.35K.
Genenta Science made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3762 holding.
GAMMA Investing first reported a position in Genenta Science in Q4 2025 and has held it in 4 quarters since.
GAMMA Investing's Genenta Science position peaked at $18.1K in Q2 2026.
5 funds tracked by Wall St. Rank held Genenta Science as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.